Duvelisib (Copiktra) is a prescription medicine used to treat adults with certain types of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has not responded to or has progressed after at least one prior treatment. Duvelisib is a kinase inhibitor that works by blocking certain proteins that cancer cells need to grow and divide.
Duvelisib, sold under the brand name Copiktra, is a medication used to treat specific types of blood cancers in adults [1, 2, 3]. Here's a breakdown of its key features:
Conditions treated with Duvelisib:
- Chronic Lymphocytic Leukemia (CLL): This is a cancer that starts in the white blood cells [1, 2].
- Small Lymphocytic Lymphoma (SLL): This is a cancer that mainly affects the lymph nodes [1, 2].
Important to note:
- Duvelisib is typically prescribed only when other treatments haven't worked or stopped working [1, 2, 3].
How Duvelisib works:
- Kinase inhibitor: It belongs to a class of drugs called PI3K inhibitors, specifically targeting phosphatidylinositol-3-kinase delta and gamma [1, 2]. These enzymes are involved in the growth and survival of cancer cells. By inhibiting them, Duvelisib helps slow down or stop the growth of cancer cells [2, 3].
Potential side effects of Duvelisib:
- Duvelisib can cause serious side effects, including [1, 2, 3]:
- Diarrhea
- Low white blood cells (increasing risk of infection)
- Rash
- Fatigue
- Fever
- Muscle aches
- Lung inflammation (pneumonitis)
- There is also a recent FDA warning about an increased risk of death associated with Duvelisib compared to some other treatments [2].
Important considerations for Duvelisib:
- It's a prescription medication and requires close monitoring by a doctor [1].
- Due to the potential for serious side effects, it's crucial to discuss the risks and benefits with your doctor to determine if Duvelisib is the right treatment for you [1, 2].
- Inform your doctor about all medications you're taking, as some can interact with Duvelisib [1].
Remember, this information is intended for general knowledge and shouldn't be a substitute for professional medical advice. Talk to your doctor for any questions or concerns you may have about Duvelisib.